Endo completes acquisition of Auxilium Pharmaceuticals
Endo announced it has completed the acquisition of Auxilium in a transaction valued at $2.6 billion when announced on Oct. 9, 2014. The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders, 2015, and the receipt of all required regulatory approvals. January 29, 2015